Quick Answer
Fortress Biotech, Inc. reported Net Income Loss of $6.82 million for the year ending 2025.
- Fortress Biotech, Inc. showed an increase of +114.8% in Net Income Loss from 2024 to 2025.
- This data is from Fortress Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 19 years of available data (2007 to 2025), Fortress Biotech, Inc.'s Net Income Loss has grown by 357.8%.
- Historical annual values: Fiscal year 2025: $6.82 million | Fiscal year 2024: -$46.00 million | Fiscal year 2023: -$60.64 million | Fiscal year 2022: -$86.58 million | Fiscal year 2021: -$64.70 million | Fiscal year 2020: -$46.53 million | Fiscal year 2019: -$39.96 million | Fiscal year 2018: -$84.15 million | Fiscal year 2017: -$66.88 million | Fiscal year 2016: -$55.10 million | Fiscal year 2015: -$48.43 million | Fiscal year 2014: -$20.39 million | Fiscal year 2013: -$37.16 million | Fiscal year 2012: -$27.61 million | Fiscal year 2011: -$36.36 million | Fiscal year 2010: -$9.98 million | Fiscal year 2009: -$3.67 million | Fiscal year 2008: -$3.80 million | Fiscal year 2007: -$2.64 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: